<?xml-stylesheet type="text/xsl" href="https://emersonexchange365.com/cfs-file/__key/system/syndication/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>BioPhorum Collaboration for Improving Biopharmaceutical Manufacturing</title><link>/industries/lifesciences/b/life-sciences-blog/posts/biophorum-collaboration-for-improving-biopharmaceutical-manufacturing</link><description>Let’s recognize the tremendous efforts by people in the Life Sciences industry racing for solutions to COVID-19 Coronavirus treatments and vaccines. In an unprecedented way, many are scaling up for full production while still in the early phases of development</description><dc:language>en-US</dc:language><generator>Telligent Community 13</generator></channel></rss>